Abstract:Zhuru Hou, 1, 2, &ast Ling Liu, 2– 4, &ast Jianhong Wei, 1 Benjin Xu 2– 4 1 Department of Basic Medicine, Fenyang College of Shanxi Medical University, Fenyang, People's Republic of China; 2 Key Laboratory of Lvliang for Clinical Molecular Diagnostics, Fenyang, People's Republic of China; 3 Department of Medical Laboratory Science, Fenyang College of Shanxi Medical University, Fenyang, People's Republic of China; 4 Department of Clinical Laboratory, Fenyang Hospital of Shanxi Province, Fenyang, People's Republic of China &astThese authors contributed equally to this work Correspondence: Jianhong Wei, Department of Basic Medicine, Fenyang College of Shanxi Medical University, Fenyang, 032200, People's Republic of China, Email Benjin Xu, Department of Medical Laboratory Science, Fenyang College of Shanxi Medical University, Fenyang, 032200, People's Republic of China, Email Staphylococcus aureus is a common human pathogen with a variety of virulence factors, which can cause multiple infectious diseases. In recent decades, due to the constant evolution and the abuse of antibiotics, Staphylococcus aureus was becoming more resistant, the infection rate of MRSA remained high, and clinical treatment of MRSA became more difficult. The genetic diversity of MRSA was mainly represented by the continuous emergence of epidemic strains, resulting in the constant changes of epidemic clones. Different classes of MRSA resulted in different epidemics and resistance characteristics, which could affect the clinical symptoms and treatments. MRSA had also spread from traditional hospitals to community and livestock environments, and the new clones established a relationship between animals and humans, promoting further evolution of MRSA. Since the resistance mechanism of MRSA is very complex, it is important to clarify these resistance mechanisms at the molecular level for the treatment of infectious diseases. We firstly described the diversity of SCC mec elements, and discussed the types of SCC mec , its drug resistance mechanisms and expression regulations. Then, we described how the vanA operon makes Staphylococcus aureus resistant to vancomycin and its expression regulation. Finally, a brief introduction was given to the drug resistance mechanisms of biofilms and efflux pump systems. Analyzing the resistance mechanism of MRSA can help study new anti-infective drugs and alleviate the evolution of MRSA. At the end of the review, we summarized the treatment strategies for MRSA infection, including antibiotics, anti-biofilm agents and efflux pump inhibitors. To sum up, here we reviewed the epidemic characteristics of Staphylococcus aureus , summarized its classifications, drug resistance mechanisms of MRSA (SCC mec element, vanA operon, biofilm and active efflux pump system) and novel therapy strategies, so as to provide a theoretical basis for the treatment of MRSA infection. Keywords: biofilm, efflux pump, MRSA, prevalence, resistance mechanism, SCC mec Staphylococcus aureus ( S. aureus ) is a kind of gram-positive conditional pathogen that widely exists in human living environment. It can asymptotically colonize the nasal cavity of normal humans. However, when the body's immune function is low, it can infect local skin and soft tissues, and even enter deep tissues and blood, causing systemic infections such as pneumonia, endocarditis, osteomyelitis and even bacteremia. 1 According to the molecular epidemiological evidences, methicillin-susceptible Staphylococcus aureus (MSSA) becomes methicillin-resistant Staphylococcus aureus (MRSA) after evolving several times. MRSA is one type of S. aureus carrying mecA/mecC gene or oxacillin MIC value≥4μg/mL, 2 which has become a multidrug-resistant bacterium that seriously threatens human health. With rapid spread and complex drug resistance mechanisms, case fatality rate in patients with clinical MRSA infection is high. Nearly 150,000 MRSA infections were reported annually in European Union countries, resulting in more than 7000 deaths. 3 And in China, the infection rate of MRSA had been maintained at over 30% for the past five years according to data from CHINET surveillance system. Otherwise, bacteremia caused by MRSA infection is a common cause of global bloodstream infections, with a mortality rate of 32.4%, and even higher in developing countries. 4 Therefore, it is extremely important to understand the prevalence of MRSA and explore strategies for preventing and treating MRSA infection. In this paper, the prevalence status and resistance mechanisms of MRSA are reviewed -Abstract Truncated-

Stability, Toxicity, and Antibacterial Potential of Gallic Acid-Loaded Graphene Oxide (GAGO) Against Methicillin-Resistant Staphylococcus aureus (MRSA) Strains

Glycyrrhizic Acid Nanoparticles Subside the Activity of Methicillin-Resistant Staphylococcus aureus by Suppressing PBP2a

PDADMAC/Alginate-Coated Gold Nanorod For Eradication of Staphylococcus Aureus Biofilms

Gallic acid exerts antibiofilm activity by inhibiting methicillin-resistant Staphylococcus aureus adhesion

Antibacterial Properties of Ethacridine Lactate and Sulfmethoxazole Loaded Functionalized Graphene Oxide Nanocomposites

Assessing the Potential of Gallic Acid and Methyl Gallate to Enhance the Efficacy of β-Lactam Antibiotics against Methicillin-Resistant Staphylococcus aureus by Targeting β-Lactamase: In Silico and In Vitro Studies

In vitro Antimicrobial Activity and the Mechanism of Berberine Against Methicillin-Resistant Staphylococcus aureus Isolated from Bloodstream Infection Patients

Targeted inhibition of methicillin-resistant Staphylococcus aureus biofilm formation by a graphene oxide-loaded aptamer/berberine bifunctional complex

Antimicrobial activities of graphene oxide against biofilm and intracellular Staphylococcus aureus isolated from bovine mastitis

Design and synthesis of novel anti-multidrug-resistant staphylococcus aureus derivatives of glycyrrhetinic acid by blocking arginine biosynthesis, metabolic and H2S biogenesis

Gallic acid synergistically enhances the antibacterial activity of azithromycin in MRSA

Effect of Graphene Oxide and Silver Nanoparticles Hybrid Composite on P. aeruginosa Strains with Acquired Resistance Genes

Effect of gallium nitrate on the antibacterial activity of vancomycin in methicillin-sensitive and resistant Staphylococcus aureus

Antimicrobial activity of a natural compound and analogs against multi-drug-resistant Gram-positive pathogens

A novel α-mangostin derivative synergistic to antibiotics against MRSA with unique mechanisms

Antimicrobial and antibiofilm effects of cyclic dipeptide-rich fraction from Lactobacillus plantarum loaded on graphene oxide nanosheets

Anti-Biofilm Effect of Ampicillin-Loaded Poly (Lactic-co-glycolic Acid) Nanoparticles Conjugated with Lysostaphin on Methicillin-Resistant Staphylococcus aureus

Enhanced Bioactivity of Streptomycin Bioconjugated Metal Nanoparticles Against Streptomycin Resistant Bacillus Sp

Effect of Ruta graveolens Extract on the Major Virulence Factors in Methicillin Resistant Staphylococcus aureus

Andrographolide Sulfonate Is a Promising Treatment to Combat Methicillin-resistant Staphylococcus aureus and Its Biofilms

Progress in the Prevalence, Classification and Drug Resistance Mechanisms of Methicillin-Resistant Staphylococcus aureus